These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32300606)

  • 1. Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China.
    Zhou C; Song W; Yin Z; Li S; Gong X; Fang Q; Wang S
    J Immunol Res; 2020; 2020():8130760. PubMed ID: 32300606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China.
    Yin Z; Wen T; Fang Q; Zheng C; Gong X; Li J; Wang S; Xiang Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2086774. PubMed ID: 35675040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.
    Ma R; Lu L; Zhou T; Pan J; Chen M; Pang X
    Vaccine; 2018 May; 36(19):2589-2595. PubMed ID: 29653850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.
    Ma C; Liu Y; Tang J; Jia H; Qin W; Su Y; Wang H; Hao L
    Hum Vaccin Immunother; 2018 Jun; 14(6):1392-1397. PubMed ID: 29377772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.
    Qin W; Wang Y; Yang T; Xu XK; Meng XM; Zhao CJ; Li SY; Xie SY; Li KC; Su H
    Hum Vaccin Immunother; 2019; 15(9):2106-2111. PubMed ID: 30779678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation on the short term effectiveness of two doses mumps-containing vaccine policy in Shandong, China].
    Xu Q; Xiong P; Fang XQ; Liu XD; Wang CY; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):265-270. PubMed ID: 29973005
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.
    Yin Z; Zheng C; Fang Q; Gong X; Cao G; Li J; Xiang Z; Song W
    J Immunol Res; 2021; 2021():5990417. PubMed ID: 34778466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
    PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.
    Wang D; Nie T; Pan F; Wang Y; Wang J; Qin W
    Hum Vaccin Immunother; 2021 Jul; 17(7):2072-2077. PubMed ID: 33545016
    [No Abstract]   [Full Text] [Related]  

  • 10. Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China.
    Li D; Zhang H; You N; Chen Z; Yang X; Zhang H; Zhou Y; Zheng N; Pan W
    Hum Vaccin Immunother; 2022 Nov; 18(6):2096375. PubMed ID: 35950847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mumps in Poland in 2018.
    Bogusz J; Paradowska-Stankiewicz I
    Przegl Epidemiol; 2020; 74(3):406-410. PubMed ID: 33570314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mumps outbreak in the Plzeň Region in 2011].
    Pazdiora P; Skálová J; Kubátová A; Ježová I; Morávková I; Podlesná I; Průchová J; Spáčilová M; Švecová M
    Epidemiol Mikrobiol Imunol; 2015 Oct; 64(4):242-9. PubMed ID: 26795229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mumps in Poland in 2012.
    Rogalska J; Paradowska-Stankiewicz I
    Przegl Epidemiol; 2014; 68(2):191-3, 317-8. PubMed ID: 25135497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of State Space model in the evaluation of the prevention and control for mumps].
    Luo C; Li RZ; Xu QQ; Xiong P; Liu YX; Xue FZ; Xu Q; Li XJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1218-1221. PubMed ID: 28910935
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological changes in mumps infections between 1990 and 2017 in urban area of Shanghai, China.
    Pang H; Zhou Y; Zhao W; Jiang Q
    Hum Vaccin Immunother; 2021 May; 17(5):1358-1365. PubMed ID: 33175643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outbreak of mumps in a small island in Japan.
    Oda K; Kato H; Konishi A
    Acta Paediatr Jpn; 1996 Jun; 38(3):224-8. PubMed ID: 8741310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend of measles, mumps, and rubella incidence following the measles-rubella catch up vaccination in the Republic of Korea, 2001.
    Choe YJ; Eom HE; Cho SI
    J Med Virol; 2017 Sep; 89(9):1528-1531. PubMed ID: 28303592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps in Poland in 2014.
    Korczyńska MR; Rogalska J
    Przegl Epidemiol; 2016; 70(2):183-187. PubMed ID: 27779832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.